Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Paradiso

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Cancer Cell|March 28, 2025
Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omicsYunhe Liu, Ansam Sinjab, Jimin Min, et al.
Cell Reports. Medicine|October 31, 2025
Identification of therapeutic targets for renal medullary carcinoma via integrated genomic and transcriptomic profilingPavlos Msaouel, Nizar M Tannir, Funda Meric-Bernstam, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
CDK8 remodels the tumor microenvironment to resist the therapeutic efficacy of targeted KRAS <sup>G12D</sup> inhibition in pancreatic ductal adenocarcinomaKathleen M McAndrews, Krishnan K Mahadevan, Bingrui Li, et al.
The EMBO Journal|July 11, 2026
CDK8 remodels the tumor microenvironment and promotes resistance to KRAS<sup>G12D</sup> inhibitors and daraxonrasib in PDACKathleen M McAndrews, Krishnan K Mahadevan, Bingrui Li, et al.
Science Translational Medicine|September 3, 2025
An allele-agnostic mutant-KRAS inhibitor suppresses tumor maintenance signals and reprograms tumor immunity in pancreatic cancerKathleen M McAndrews, Francesca Paradiso, Clint A Stalnecker, et al.
Cancer Discovery|July 8, 2024
Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic CancerJulien Dilly, Megan T Hoffman, Laleh Abbassi, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Cancer Cell|March 28, 2025
Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omicsYunhe Liu, Ansam Sinjab, Jimin Min, et al.
Cell Reports. Medicine|October 31, 2025
Identification of therapeutic targets for renal medullary carcinoma via integrated genomic and transcriptomic profilingPavlos Msaouel, Nizar M Tannir, Funda Meric-Bernstam, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
CDK8 remodels the tumor microenvironment to resist the therapeutic efficacy of targeted KRAS <sup>G12D</sup> inhibition in pancreatic ductal adenocarcinomaKathleen M McAndrews, Krishnan K Mahadevan, Bingrui Li, et al.
The EMBO Journal|July 11, 2026
CDK8 remodels the tumor microenvironment and promotes resistance to KRAS<sup>G12D</sup> inhibitors and daraxonrasib in PDACKathleen M McAndrews, Krishnan K Mahadevan, Bingrui Li, et al.
Science Translational Medicine|September 3, 2025
An allele-agnostic mutant-KRAS inhibitor suppresses tumor maintenance signals and reprograms tumor immunity in pancreatic cancerKathleen M McAndrews, Francesca Paradiso, Clint A Stalnecker, et al.
Cancer Discovery|July 8, 2024
Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic CancerJulien Dilly, Megan T Hoffman, Laleh Abbassi, et al.
Pageof 3